|Application:||Gene expression microarray analysis|
|Number of samples:||49|
|Release date:||Apr 1 2013|
|Last update date:||Aug 9 2018|
|Diseases:||Carcinoma, Hepatocellular, Ventricular Dysfunction|
|Dataset link||Low SLC22A7 expression in noncancerous liver promotes hepatocellular carcinoma occurrence - a prospective study|
The 49 noncancerous liver tissues of HCC patients within Milan criteria, treated at our institution between January 2004 and August 2008, were examined as a training set by genome-wide gene expression analysis (GA). Cox proportional hazards regression analyses for MO-free survival (MFS) were performed to estimate the risk factors. Using the independent two institutional cohorts of 134 patients between September 2008 and December 2009, a validation study was employed using tissue microarrays.